ESMO's not what it used to be—and that's a good thing, executives say

23rd October 2018 Uncategorised 0

As the European Society for Medical Oncology meeting comes to a close, one thing is clear: ESMO isn’t the meeting it used to be. And the way biopharma executives see it, that’s a good thing.

More: ESMO's not what it used to be—and that's a good thing, executives say
Source: fierce